Nuclera joins Tech Nation’s Future Fifty program
Nuclera, the biotechnology company enabling rapid protein expression and purification screening through its eProtein Discovery benchtop protein platform, today announced it has been selected to join the Tech Nation Future Fifty 2024 cohort, a...
Sylvester receives 2 US Department of Defense grants to study endometrial cancer in Black...
MIAMI, FLORIDA (March 20, 2024) – Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have received two new three-year, $1 million grants from the U.S. Department of...
PROTAC Drug Candidates Could Offer Up Strategy for Eliminating HIV Reservoir
University of Pittsburgh School of Medicine scientists have developed drug candidates that early tests suggest could reverse HIV’s ability to escape detection by the immune system. The team’s research was centered on developing drugs...
Three-dimensional image of the symbiotic communities around plant roots
Animals and plants form complex symbiotic communities with microorganisms, the so-called microbiome. A research team from Heinrich Heine University Düsseldorf (HHU) and the Max Planck Institute for Plant Breeding Research (MPIPZ) in Cologne has...
GTC 2024: Nvidia Highlights AI ‘Revolution’ in Drug Discovery, Genomics
SAN JOSE, CA—Just as users train artificial intelligence (AI) models to search for a druggable target or predict the structure of a protein, so Nvidia founder and CEO Jensen Huang says he trained himself...
Newly identified yeast could prevent fungal infections by outcompeting rivals, study suggests
Researchers at the Weizmann Institute of Science in Israel have identified a yeast that could be used to prevent invasive candidiasis, a major cause of death in hospitalized and immunocompromised patients. The study, to...
Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer...
Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that its ArrayPlex™ discovery platform has been selected by Immunome, Inc. (NASDAQ: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies,...
Better kombucha brewing through chemistry
NEW ORLEANS, March 17, 2024 — Kombucha is a fermented tea known for its health benefits and tangy kick. But brewers can find it challenging to keep kombucha’s alcohol levels low because the bacteria...
10x Defends Patent Litigation Strategy after Criticism from Researchers, Rivals
10x Genomics co-founder and CEO Serge Saxonov, PhD
Buffeted for weeks by criticism from competitors and leading academic researchers in the spatial biology community, 10x Genomics is defending its strategy of aggressively litigating potential infringement...
StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug
Madrigal Pharmaceuticals (MDGL) appears to have a blockbuster on its hands in Rezdiffra (resmetirom), the metabolic dysfunction-associated steatohepatitis (MASH) treatment that won an historic FDA accelerated approval on Thursday—the first therapy to win agency...
